Pfizer (PFE) Cash & Equivalents Growth (5y) (2014 - 2026)

Pfizer (PFE) Cash & Equivalents Growth (5y) (2014 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Mar 29, 2026 -0.75%
Dec 31, 2025 -8.56%
Sep 28, 2025 -3.28%
Jun 29, 2025 -1.88%
Mar 30, 2025 -7.84%
Dec 31, 2024 -1.43%
Sep 29, 2024 -17.08%
Jun 30, 2024 -10.02%
Mar 31, 2024 -17.98%
Dec 31, 2023 20.16%
Oct 1, 2023 -2.42%
Jul 2, 2023 -0.54%
Apr 2, 2023 -2.16%
Dec 31, 2022 -21.89%
Oct 2, 2022 -14.60%
Jul 3, 2022 -7.73%
Apr 3, 2022 -9.77%
Dec 31, 2021 -6.12%
Oct 3, 2021 -1.25%
Jul 4, 2021 -7.01%